Dynamic Growth of the Next-Generation Antibody Therapeutics Market Driven by Increasing Chronic Diseases

The Business Research Company’s Next-Generation Antibody Therapeutics Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032

LONDON, GREATER LONDON, UK, October 24, 2023 /EINPresswire.com/ -- Projected 2027 Outlook And Catalyst: Surging Prevalence of Chronic Diseases
The next-generation antibody therapeutics market is anticipated to reach $9.43 billion in 2027, exhibiting a compound annual growth rate (CAGR) of 11.3%. The escalating prevalence of chronic diseases remains a significant driver of growth in the next-generation antibody therapeutics market. These novel therapies play a crucial role in providing targeted treatment for individuals grappling with chronic illnesses, significantly improving patient outcomes. According to projections from the National Center for Biotechnology Information (NCBI), the number of individuals aged 50 years and older with at least one chronic illness is estimated to surge by 99.5% by 2050, underscoring the critical need for effective next-generation antibody therapeutics.

Innovative Solutions as Market Trend
Industry leaders such as Merck KGaA are focused on technological advancements to enhance their product portfolios. For instance, Merck KGaA's introduction of ChetoSensar in October 2021, a technology addressing solubility issues, signifies a significant leap in the development of antibody-drug conjugates. By improving the efficacy and solubility of antibody-drug conjugates and high-potency active pharmaceutical ingredients (HPAPI), ChetoSensar broadens the scope for creating next-generation antibody-drug conjugate therapeutics, marking a pivotal step forward in the field.

Strategic Acquisitions to Foster Research Initiatives
AbbVie's acquisition of DJS Antibodies Ltd. in October 2022 highlights the industry's strategic emphasis on bolstering research capabilities and expanding immunology portfolios. This move empowers companies like AbbVie to leverage new tools for advancing their antibody research, fueling heightened research efforts and fostering growth opportunities within the thriving bioscience sector.

Explore the latest trends and growth opportunities in the Global Next-Generation Antibody Therapeutics Market with our sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12678&type=smp

Key Market Players
Prominent entities propelling the growth and innovation in the next-generation antibody therapeutics market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, AstraZeneca plc, and Amgen Inc., among others. These industry leaders are at the forefront of advancing technology and research to address the evolving demands of the market.

Geographical Analysis
North America retained its position as the largest region in the next-generation antibody therapeutics market in 2022, while Asia-Pacific is poised to witness the fastest growth during the forecast period. The report encompasses a comprehensive analysis of regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Market Segmentation:
•Types of Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Biospecific Antibodies, Antibody-Drug Conjugates, Other Types
•Therapeutic Area: Oncology, Autoimmune Diseases, Infectious Diseases, Neurodegenerative Disorders, Other Therapeutic Areas
•End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Gain comprehensive insights into the factors driving the growth of the Global Next-Generation Antibody Therapeutics Market with our detailed report -
https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

Next Generation Antibody Therapeutics Global Market Report 2023 from TBRC covers the following information:
•Market size date for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Next Generation Antibody Therapeutics Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on next generation antibody therapeutics market size, next generation antibody therapeutics market drivers and trends, next generation antibody therapeutics market major players, next generation antibody therapeutics market competitors' revenues, next-generation antibody therapeutics market positioning, and next generation antibody therapeutics market growth across geographies. The next generation antibody therapeutics market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Digital Therapeutics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

Peptide Therapeutics Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Biosimilar Therapeutic Peptides Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube

Food and Beverages Market Growth Forecast 2023-2027